| Malaygiri Jayramgiri Aparnath, MD | |
|
9900 Talbert Ave Ste 100, Fountain Valley, CA 92708-5153 | |
| (949) 521-7161 | |
| (714) 698-8081 |
| Full Name | Malaygiri Jayramgiri Aparnath |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 16 Years |
| Location | 9900 Talbert Ave Ste 100, Fountain Valley, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497937460 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | A105370 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorialcare Orange Coast Medical Center | Fountain valley, CA | Hospital |
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376646869 PECOS PAC ID: 3577476761 Enrollment ID: O20031112000695 |
News Archive
Erchonia, the global leader in low level laser healthcare applications, today announces the launch of the Zerona® body-contouring laser in South East Asia's SAARC. Erchonia Asia will exclusively market and sell the Zerona throughout the region. This new expansion coincides with the recent U.S. FDA-approval of the Zerona Laser, a non-invasive, painless treatment that guarantees the removal of fat.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, today announced that Healthfirst, Inc., will implement Star Advantage, MedAssurant's quality outcomes improvement solution that enables health plans to both better understand and meaningfully impact their CMS Five-Star Quality Ratings.
For the first time, researchers have managed to home in on a molecular process in the brain that contributes to the development of schizophrenia.
The lack of progress in reducing children's exposures to pesticides, despite passage in 1996 of the Food Quality Protection Act (FQPA), will be highlighted during a symposium organized by The Organic Center on Sunday, February 19th at the 2006 annual meeting of the American Association for the Advancement of Science (AAAS).
A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that it has entered into a license and development agreement with Merial, a world leading animal health company, for a long-acting pain management product.
› Verified 1 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386762300 PECOS PAC ID: 3577476761 Enrollment ID: O20040430001307 |
News Archive
Erchonia, the global leader in low level laser healthcare applications, today announces the launch of the Zerona® body-contouring laser in South East Asia's SAARC. Erchonia Asia will exclusively market and sell the Zerona throughout the region. This new expansion coincides with the recent U.S. FDA-approval of the Zerona Laser, a non-invasive, painless treatment that guarantees the removal of fat.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, today announced that Healthfirst, Inc., will implement Star Advantage, MedAssurant's quality outcomes improvement solution that enables health plans to both better understand and meaningfully impact their CMS Five-Star Quality Ratings.
For the first time, researchers have managed to home in on a molecular process in the brain that contributes to the development of schizophrenia.
The lack of progress in reducing children's exposures to pesticides, despite passage in 1996 of the Food Quality Protection Act (FQPA), will be highlighted during a symposium organized by The Organic Center on Sunday, February 19th at the 2006 annual meeting of the American Association for the Advancement of Science (AAAS).
A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that it has entered into a license and development agreement with Merial, a world leading animal health company, for a long-acting pain management product.
› Verified 1 days ago
| Entity Name | Saddleback Respiratory Medical Grp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164517843 PECOS PAC ID: 4385686492 Enrollment ID: O20050531000435 |
News Archive
Erchonia, the global leader in low level laser healthcare applications, today announces the launch of the Zerona® body-contouring laser in South East Asia's SAARC. Erchonia Asia will exclusively market and sell the Zerona throughout the region. This new expansion coincides with the recent U.S. FDA-approval of the Zerona Laser, a non-invasive, painless treatment that guarantees the removal of fat.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, today announced that Healthfirst, Inc., will implement Star Advantage, MedAssurant's quality outcomes improvement solution that enables health plans to both better understand and meaningfully impact their CMS Five-Star Quality Ratings.
For the first time, researchers have managed to home in on a molecular process in the brain that contributes to the development of schizophrenia.
The lack of progress in reducing children's exposures to pesticides, despite passage in 1996 of the Food Quality Protection Act (FQPA), will be highlighted during a symposium organized by The Organic Center on Sunday, February 19th at the 2006 annual meeting of the American Association for the Advancement of Science (AAAS).
A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that it has entered into a license and development agreement with Merial, a world leading animal health company, for a long-acting pain management product.
› Verified 1 days ago
| Entity Name | Inpatient Specialists Of California Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952792475 PECOS PAC ID: 3476864448 Enrollment ID: O20150617000915 |
News Archive
Erchonia, the global leader in low level laser healthcare applications, today announces the launch of the Zerona® body-contouring laser in South East Asia's SAARC. Erchonia Asia will exclusively market and sell the Zerona throughout the region. This new expansion coincides with the recent U.S. FDA-approval of the Zerona Laser, a non-invasive, painless treatment that guarantees the removal of fat.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, today announced that Healthfirst, Inc., will implement Star Advantage, MedAssurant's quality outcomes improvement solution that enables health plans to both better understand and meaningfully impact their CMS Five-Star Quality Ratings.
For the first time, researchers have managed to home in on a molecular process in the brain that contributes to the development of schizophrenia.
The lack of progress in reducing children's exposures to pesticides, despite passage in 1996 of the Food Quality Protection Act (FQPA), will be highlighted during a symposium organized by The Organic Center on Sunday, February 19th at the 2006 annual meeting of the American Association for the Advancement of Science (AAAS).
A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that it has entered into a license and development agreement with Merial, a world leading animal health company, for a long-acting pain management product.
› Verified 1 days ago
| Entity Name | Pulmonarius Asclepius Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326503202 PECOS PAC ID: 5193064848 Enrollment ID: O20190225002514 |
News Archive
Erchonia, the global leader in low level laser healthcare applications, today announces the launch of the Zerona® body-contouring laser in South East Asia's SAARC. Erchonia Asia will exclusively market and sell the Zerona throughout the region. This new expansion coincides with the recent U.S. FDA-approval of the Zerona Laser, a non-invasive, painless treatment that guarantees the removal of fat.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, today announced that Healthfirst, Inc., will implement Star Advantage, MedAssurant's quality outcomes improvement solution that enables health plans to both better understand and meaningfully impact their CMS Five-Star Quality Ratings.
For the first time, researchers have managed to home in on a molecular process in the brain that contributes to the development of schizophrenia.
The lack of progress in reducing children's exposures to pesticides, despite passage in 1996 of the Food Quality Protection Act (FQPA), will be highlighted during a symposium organized by The Organic Center on Sunday, February 19th at the 2006 annual meeting of the American Association for the Advancement of Science (AAAS).
A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that it has entered into a license and development agreement with Merial, a world leading animal health company, for a long-acting pain management product.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Malaygiri Jayramgiri Aparnath, MD 9900 Talbert Ave Ste 100, Fountain Valley, CA 92708-5153 Ph: (948) 521-7161 | Malaygiri Jayramgiri Aparnath, MD 9900 Talbert Ave Ste 100, Fountain Valley, CA 92708-5153 Ph: (949) 521-7161 |
News Archive
Erchonia, the global leader in low level laser healthcare applications, today announces the launch of the Zerona® body-contouring laser in South East Asia's SAARC. Erchonia Asia will exclusively market and sell the Zerona throughout the region. This new expansion coincides with the recent U.S. FDA-approval of the Zerona Laser, a non-invasive, painless treatment that guarantees the removal of fat.
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, today announced that Healthfirst, Inc., will implement Star Advantage, MedAssurant's quality outcomes improvement solution that enables health plans to both better understand and meaningfully impact their CMS Five-Star Quality Ratings.
For the first time, researchers have managed to home in on a molecular process in the brain that contributes to the development of schizophrenia.
The lack of progress in reducing children's exposures to pesticides, despite passage in 1996 of the Food Quality Protection Act (FQPA), will be highlighted during a symposium organized by The Organic Center on Sunday, February 19th at the 2006 annual meeting of the American Association for the Advancement of Science (AAAS).
A.P. Pharma (Nasdaq:APPA), a specialty pharmaceutical company, today announced that it has entered into a license and development agreement with Merial, a world leading animal health company, for a long-acting pain management product.
› Verified 1 days ago
Dr. Kristine Suzanne Olson Arthur, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 11420 Warner Ave, Fountain Valley, CA 92708 Phone: 714-549-1300 Fax: 714-433-3100 | |
Dr. Sajeet Singh Sawhney, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 11100 Warner Ave, Suite 218, Fountain Valley, CA 92708 Phone: 714-641-9696 Fax: 714-641-9696 | |
Dr. Jennifer L Wong, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 18111 Brookhurst St Ste 5100, Fountain Valley, CA 92708 Phone: 714-546-2238 Fax: 714-434-8145 | |
Dr. Sithu Lin, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 11100 Warner Ave Ste 218, Fountain Valley, CA 92708 Phone: 714-641-9696 | |
Kien-an Duong, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 11420 Warner Ave, Fountain Valley, CA 92708 Phone: 714-549-1300 Fax: 714-433-3100 | |
Mr. Satinder Swaroop, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 11180 Warner Ave, Suite #353, Fountain Valley, CA 92708 Phone: 714-751-3540 Fax: 714-751-5626 | |
Yu-ming Ni, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 18111 Brookhurst St Ste 5100, Fountain Valley, CA 92708 Phone: 714-546-2238 |